Works matching IS 03125963 AND DT 2023 AND VI 62 AND IP 7


Results: 12
    1
    2
    3
    4
    5
    6
    7

    Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer.

    Published in:
    Clinical Pharmacokinetics, 2023, v. 62, n. 7, p. 989, doi. 10.1007/s40262-023-01255-1
    By:
    • Detert Oude Weme, S. E. H.;
    • Hulskotte, L. M. G.;
    • Vervenne, W. L.;
    • Imholz, A. L. T.;
    • Cremers, R. G. H. M.;
    • Taxis, K.;
    • Reyners, A. K. L.;
    • van Berlo-van de Laar, I. R. F.;
    • Jansman, F. G. A.;
    • Benoist, G. E.
    Publication type:
    Article
    8
    9
    10
    11
    12

    Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions.

    Published in:
    Clinical Pharmacokinetics, 2023, v. 62, n. 7, p. 1031, doi. 10.1007/s40262-023-01248-0
    By:
    • Cattani, Vitória Berg;
    • Jalil, Emilia Moreira;
    • Eksterman, Leonardo;
    • Torres, Thiago;
    • Wagner Cardoso, Sandra;
    • Castro, Cristiane R. V.;
    • Monteiro, Laylla;
    • Wilson, Erin;
    • Bushman, Lane;
    • Anderson, Peter;
    • Veloso, Valdilea Gonçalves;
    • Grinsztejn, Beatriz;
    • Estrela, Rita;
    • the PrEParadas study team;
    • Hoagland, Brenda;
    • Moura, Isabele;
    • Waite, Daniel M. McMahon;
    • Vieira, Desirée;
    • Granjeiro, José Roberto;
    • Freitas, Josias
    Publication type:
    Article